Patents by Inventor Charlotte Teunissen

Charlotte Teunissen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20130029864
    Abstract: The invention relates to novel marker sequences for Alzheimer's disease, in particular Alzheimer's dementia, and their diagnostic use including a screening method in order to identify potential drugs for the treatment/prophylaxis of Alzheimer's disease by means of the said novel marker sequences. Moreover, the invention relates to a diagnostic device comprising said novel marker sequences for diagnosing Alzheimer's disease, particularly a protein array (chip) and its use hereto.
    Type: Application
    Filed: October 1, 2010
    Publication date: January 31, 2013
    Applicant: PROTAGEN Aktiengesellschaft
    Inventors: Angelika Lueking, Stefan Müllner, Charlotte Teunissen, Jens Wiltfang
  • Patent number: 7365049
    Abstract: The use of Afamin, in particular in combination with vitamin E is described for producing a preparation for the treatment of oxidative stress.
    Type: Grant
    Filed: April 30, 2002
    Date of Patent: April 29, 2008
    Assignee: Vitateg Biotechnology GmbH
    Inventors: Michael Becker-Andre, Hans Dieplinger, Charlotte Teunissen, Lidija Jerkovic
  • Publication number: 20040235718
    Abstract: The use of Afamin, in particular in combination with vitamin E is described for producing a preparation for the treatment of oxidative stress.
    Type: Application
    Filed: June 21, 2004
    Publication date: November 25, 2004
    Inventors: Michael Becker-Andre, Hans Dieplinger, Charlotte Teunissen, Lidija Jerkovic